3 results
The primary objectives of this study are to compare the percentage of subjects achieving SVR12 (HCV RNA < lower limit of quantification [LLOQ] 12 weeks following treatment) of 12 weeks of treatment with ABT-450/r/ABT-267 and ABT-333 co-…
The primary objective of this study is to compare the response rate of Pexidartinib with that of placebo per Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST 1.1) at Week 25 in subjects with symptomatic, locally advanced PVNS or GCT…
The aim of this prospective randomized, double blind study is to evaluate the analgesic effects of pre-operative PECS II-block with (long-acting) liposomal Bupivacaine versus (short-acting) Levobupivacaine for patients undergoing a mastectomy.